These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28089180)

  • 1. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
    Bhatt DL; Grosser T; Dong JF; Logan D; Jeske W; Angiolillo DJ; Frelinger AL; Lei L; Liang J; Moore JE; Cryer B; Marathi U
    J Am Coll Cardiol; 2017 Feb; 69(6):603-612. PubMed ID: 28089180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
    Cox D; Maree AO; Dooley M; Conroy R; Byrne MF; Fitzgerald DJ
    Stroke; 2006 Aug; 37(8):2153-8. PubMed ID: 16794200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
    J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study.
    Loprete L; Leuratti C; Scarsi C; Radicioni M
    Clin Drug Investig; 2014 Jan; 34(1):19-25. PubMed ID: 24132773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS).
    Elshafei MN; Imam Y; Mohamed MFH; AlSaud AE; Ahmed MS; Obeidat K; Saeid R; Ali M; Abdallah IM; Parray AS; Danjuma MI
    Medicine (Baltimore); 2020 May; 99(20):e20307. PubMed ID: 32443379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
    Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial.
    Schoergenhofer C; Hobl EL; Schwameis M; Gelbenegger G; Staudinger T; Heinz G; Speidl WS; Zauner C; Reiter B; Lang I; Jilma B
    Eur J Clin Invest; 2017 Jul; 47(7):504-512. PubMed ID: 28556061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution.
    Feldman M; Cryer B
    Am J Cardiol; 1999 Aug; 84(4):404-9. PubMed ID: 10468077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy.
    Good RI; McGarrity A; Sheehan R; James TE; Miller H; Stephens J; Watkins S; McConnachie A; Goodall AH; Oldroyd KG
    Platelets; 2015; 26(1):17-24. PubMed ID: 24433337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.
    Finneran MM; Gonzalez-Brown VM; Smith DD; Landon MB; Rood KM
    Am J Obstet Gynecol; 2019 Apr; 220(4):385.e1-385.e6. PubMed ID: 30786253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action.
    Patrignani P; Tacconelli S; Piazuelo E; Di Francesco L; Dovizio M; Sostres C; Marcantoni E; Guillem-Llobat P; Del Boccio P; Zucchelli M; Patrono C; Lanas A
    J Thromb Haemost; 2014 Aug; 12(8):1320-30. PubMed ID: 24942808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
    Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
    Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis.
    Brown N; May JA; Wilcox RG; Allan LM; Wilson AM; Kiff PS; Heptinstall S
    Br J Clin Pharmacol; 1999 Jul; 48(1):57-62. PubMed ID: 10383561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study.
    Elshafei MN; Imam Y; Alsaud AE; Chandra P; Parray A; Abdelmoneim MS; Obeidat K; Saeid R; Ali M; Ayadathil R; Mohamed MFH; Abdallah IM; Mohammed S; Akhtar N; Danjuma MI
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1801-1811. PubMed ID: 36121499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin dosage and thromboxane synthesis in patients with vascular disease.
    Hart RG; Leonard AD; Talbert RL; Pearce LA; Cornell E; Bovill E; Feinberg WM
    Pharmacotherapy; 2003 May; 23(5):579-84. PubMed ID: 12741431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.